journal article·2021-12Open access

Injectable Nanocomposite Implants Reduce ROS Accumulation and Improve Heart Function after Infarction

Malka Shilo, Hadas Oved, Lior Wertheim, Idan Gal, Nadav Noor, Ori Green, Ester‐Sapir Baruch, Doron Shabat, Assaf Shapira, Tal Dvir

Advanced Science· Volume 8· Issue 24

Abstract

Abstract In a myocardial infarction, blood supply to the left ventricle is abrogated due to blockage of one of the coronary arteries, leading to ischemia, which further triggers the generation of reactive oxygen species (ROS). These sequential processes eventually lead to the death of contractile cells and affect the integrity of blood vessels, resulting in the formation of scar tissue. A new heart therapy comprised of cardiac implants encapsulated within an injectable extracellular matrix‐gold nanoparticle composite hydrogel is reported. The particles on the collagenous fibers within the hydrogel promote fast transfer of electrical signal between cardiac cells, leading to the functional assembly of the cardiac implants. The composite hydrogel is shown to absorb reactive oxygen species in vitro and in vivo in mice ischemia reperfusion model. The reduction in ROS levels preserve cardiac tissue morphology and blood vessel integrity, reduce the scar size and the inflammatory response, and significantly prevent the deterioration of heart function.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Cardiac Ischemia and Reperfusion

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Shmunis School of Biomedicine and Cancer Research Faculty of Life Sciences Tel Aviv University Tel Aviv 6997801 Israel

School of Chemistry Faculty of Exact Sciences Tel Aviv University Tel Aviv 6997801 Israel

The Center for Nanoscience and Nanotechnology Tel Aviv University Tel Aviv 6997801 Israel

The Department of Biomedical Engineering Faculty of Engineering Tel Aviv University Tel Aviv 6997801 Israel

Sagol Center for Regenerative Biotechnology Tel Aviv University Tel Aviv 6997801 Israel

Funding

Moxie Foundation

References (65)

Show source-provided references
1. 10.1161/CIR.000000000000065910.1161/CIR.0000000000000659 ↗
2. 10.1161/JAHA.117.00840710.1161/JAHA.117.008407 ↗
3. 10.1016/j.cardiores.2003.10.02510.1016/j.cardiores.2003.10.025 ↗
4. 10.2174/13892011279886878210.2174/138920112798868782 ↗
5. 10.1016/j.freeradbiomed.2018.01.02410.1016/j.freeradbiomed.2018.01.024 ↗
6. 10.1016/S0008-6363(00)00078-X10.1016/S0008-6363(00)00078-X ↗
7. 10.1056/NEJMra07166710.1056/NEJMra071667 ↗
8. 10.1073/pnas.84.5.140410.1073/pnas.84.5.1404 ↗
9. 10.1016/j.cardiores.2006.02.02510.1016/j.cardiores.2006.02.025 ↗
10. 10.1161/CIRCULATIONAHA.109.19266610.1161/CIRCULATIONAHA.109.192666 ↗
11. Jezovnik M. K. · Eur. Soc. Cardiol. · 2017 · 14 · 37
12. 10.1007/s11936-012-0184-710.1007/s11936-012-0184-7 ↗
13. 10.1016/j.healun.2011.08.00410.1016/j.healun.2011.08.004 ↗
14. 10.1016/J.HEALUN.2015.10.02310.1016/J.HEALUN.2015.10.023 ↗
15. 10.1016/j.copbio.2012.10.01610.1016/j.copbio.2012.10.016 ↗
16. 10.1089/ten.teb.2009.035210.1089/ten.teb.2009.0352 ↗
17. 10.1038/nnano.2010.24610.1038/nnano.2010.246 ↗
18. 10.1126/scitranslmed.aad230410.1126/scitranslmed.aad2304 ↗
19. 10.1002/admt.20190082010.1002/admt.201900820 ↗
20. 10.1002/adma.20180389510.1002/adma.201803895 ↗
21. 10.1038/nmat459010.1038/nmat4590 ↗
22. 10.1016/j.biomaterials.2013.07.05410.1016/j.biomaterials.2013.07.054 ↗
23. 10.1073/pnas.161572811410.1073/pnas.1615728114 ↗
24. 10.1002/bit.2518510.1002/bit.25185 ↗
25. 10.1088/1758-5082/6/2/02410110.1088/1758-5082/6/2/024101 ↗
26. 10.1002/smll.20190480610.1002/smll.201904806 ↗
27. 10.1021/nl502673m10.1021/nl502673m ↗
28. 10.1088/1748-6041/10/3/03410610.1088/1748-6041/10/3/034106 ↗
29. 10.1021/acs.nanolett.7b0492410.1021/acs.nanolett.7b04924 ↗
30. 10.1126/science.119203310.1126/science.1192033 ↗
31. 10.1109/TNANO.2009.203180710.1109/TNANO.2009.2031807 ↗
32. 10.1021/nl900096z10.1021/nl900096z ↗
33. 10.1016/j.nantod.2016.12.01410.1016/j.nantod.2016.12.014 ↗
34. 10.1016/j.neuron.2015.02.03310.1016/j.neuron.2015.02.033 ↗
35. 10.1371/journal.pone.009136010.1371/journal.pone.0091360 ↗
36. 10.1038/nnano.2008.37410.1038/nnano.2008.374 ↗
37. 10.1021/nl050637m10.1021/nl050637m ↗
38. 10.1038/nnano.2011.16010.1038/nnano.2011.160 ↗
39. Davidson S. M. · J. Am. Heart Assoc. · 2018 · 138 · 2837
40. 10.1038/nm.250710.1038/nm.2507 ↗
41. 10.1016/j.redox.2015.08.02010.1016/j.redox.2015.08.020 ↗
42. 10.1016/B978-0-12-394309-5.00006-710.1016/B978-0-12-394309-5.00006-7 ↗
43. 10.1002/smll.20200503810.1002/smll.202005038 ↗
44. 10.1016/j.cej.2021.12935210.1016/j.cej.2021.129352 ↗
45. 10.1039/df951110005510.1039/df9511100055 ↗
46. 10.3390/polym1102027510.3390/polym11020275 ↗
47. 10.1016/j.colsurfb.2012.06.00610.1016/j.colsurfb.2012.06.006 ↗
48. 10.1002/adma.20160028410.1002/adma.201600284 ↗
49. 10.1089/ten.2006.12.284310.1089/ten.2006.12.2843 ↗
50. 10.1021/jacs.7b0844610.1021/jacs.7b08446 ↗
51. 10.1016/j.ynstr.2017.01.00110.1016/j.ynstr.2017.01.001 ↗
52. Marwick T. H. · Eur. Heart J. Cardiovasc. Imaging · 2015 · 16 · 577
53. 10.1111/jch.1284910.1111/jch.12849 ↗
54. 10.1038/nm139410.1038/nm1394 ↗
55. 10.1016/j.mayocp.2018.07.01710.1016/j.mayocp.2018.07.017 ↗
56. 10.1016/j.jacc.2017.06.04610.1016/j.jacc.2017.06.046 ↗
57. 10.1114/1.130848710.1114/1.1308487 ↗
58. 10.1152/ajpheart.1994.267.1.H31910.1152/ajpheart.1994.267.1.H319 ↗
59. 10.1038/ncpcardio040410.1038/ncpcardio0404 ↗
60. 10.1021/cr200233g10.1021/cr200233g ↗
61. 10.1021/ja034830z10.1021/ja034830z ↗
62. 10.1161/CIRCRESAHA.116.30959810.1161/CIRCRESAHA.116.309598 ↗
63. 10.1038/nrcardio.2014.2810.1038/nrcardio.2014.28 ↗
64. 10.1089/ars.2011.412310.1089/ars.2011.4123 ↗
65. 10.1016/j.redox.2018.08.00810.1016/j.redox.2018.08.008 ↗